Industry Portals
Pharmaceutical Industry News
Integer a velit nec risus malesuada imperdiet id et odio. Nunc sit amet mauris dapibus, feugiat diam eget, suscipit, nam gravida nulla eget turpis commodo.
Young & Partners Forum Series: The Energy Transition and its Implications- Jason Bordoff of Columbia University SIPA
Jason Bordoff, Founding Director of the Center on Global Energy Policy, Columbia University SIPA; Previously Special Assistant to President Barack Obama and Senior Director for Energy and Climate Change, the Staff of the National Security Council Peter Young, President and CEO, Young & Partners
The Chemical M&A Market Treads Water (August 12, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Chemical M&A market in the first half of 2025 and the outlook.
Pharma and Biotech: M&A Review and Outlook
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in the first half of 2025 and the outlook.
Peter Young Receives the Foreign Policy Association Medal
Peter Young, Chief Executive Officer of Young & Partners was awarded the Foreign Policy Association Medal Award at a dinner held at the Harvard Club of New York on June 26. Past recipients include the Honorable Michael Bloomberg, Mayor, New York City; Timothy Geithner, Chairman, Federal Reserve Bank of New York; Jean-Claude Trichet, President of the European Central Bank; Kevin Rudd, Prime Minister, Australia; Sheila C. Bair, Chairman, Federal Deposit Insurance Corporation, and Anne-Marie Slaughter, Dean, Woodrow Wilson School of Public and International Affairs, Princeton University, among others.
Chemical Stock Market and Funding in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis and outlook of Chemical stock market and funding market in the first quarter of 2025 and the outlook for the rest of 2025.
Biotech and Pharma Stock Market and Funding in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma Stock Market and Funding in the first quarter of 2025 and the outlook.
Chemical M&A in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis and outlook of Chemical M&A in the first quarter of 2025 and the outlook for the M&A market in the rest of 2025.
Biotech and Pharma M&A in the First Quarter 2025 and Beyond
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in the first quarter of 2025 and the outlook.
Chemical Executives Deal with Tariffs (ICIS Chemical Business May 9 – May 15, 2025)
ICIS Chemical Business reports on panel discussion (Apollo, Dow and Westlake executives) moderated by Peter Young on April 30, 2025.
Young & Partners Forum Series: How to Build an Effective Salesforce – Adam Woodrow of Paratek Pharmaceuticals
Adam Woodrow, President and Chief Commercial Officer, Paratek Pharmaceuticals Peter Young, President and CEO, Young & Partners
Young & Partners Forum Series: Drug Innovation Insights – Lessons From History – William Pao of Revelio Therapeutics
William Pao, CEO of Revelio Therapeutics and Former Chief Development Officer and Executive Vice President for Pfizer Peter Young, President and CEO, Young & Partners
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Biopharma Business Check – Financing and Review (Pharmaceutical Executive, February 2025)
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Global M&A Treads Water
Young & Partners shares proprietary analysis of the Chemicals M&A market and their outlook for 2025.
Divestitures in the Current Environment
Young & Partners shares proprietary analysis of the Chemicals M&A market and proposes questions for Chemicals owners to think over as significant asset rationalization occurs globally.
Reflections on 2024 and Outlook – Stock Market and Funding
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Reflections on 2024 and Outlook – Senior Management Approach to M&A
Young & Partners shares proprietary analysis and outlook of how managers and executive should approach Biotech and Pharma M&A market in 2025.
Reflections on 2024 and Outlook – Biotech and Pharma M&A
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in 2024 and the outlook for 2025.
Young & Partners 2024 Chemical Conference: Speakers Roundtable- What Does the Future Hold?
Joe Chang, Global Editor, ICIS Chemical Business Stephen Floyd, Managing Director, Young & Partners Dewey Johnson, SVP Chemical Market Analytics Lien-Hang T. Nguyen, Director of the Weatherhead East Asian Institute, Columbia University Charlie Vest, Associate Director, China Practice, Rhodium Group Peter Young, President and CEO, Young & Partners